US2012171235A1PendingUtilityA1

Markers of xmrv infection and uses thereof

43
Assignee: QIU XIAOXINGPriority: Jun 30, 2009Filed: Mar 7, 2012Published: Jul 5, 2012
Est. expiryJun 30, 2029(~3 yrs left)· nominal 20-yr term from priority
Inventors:Xiaoxing QiuJohn R. Hackett, Jr.Ka-Cheung X. LukPriscilla Swanson
A61P 37/04A61P 31/14A61P 35/02A61P 35/00C07K 2319/21A61P 13/08C07K 2317/76C07K 2317/21C07K 2317/34C12N 2740/13022A61P 15/00C07K 2319/00C07K 14/005C07K 16/112A61K 39/00
43
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates generally to assays for the detection of Xenotropic Murine Leukemia Virus-related Retrovirus (“XMRV”) and diseases associated with XMRV infection. Additionally, the invention relates to specific XMRV antigens capable of inducing an immunogenic response as well as XMRV-related nucleic acids having significant diagnostic, screening, and therapeutic utilities.

Claims

exact text as granted — not AI-modified
1 . A method of inducing an immune response to an XMRV in an individual in need thereof, comprising administering to the individual an effective amount of an antigenic peptide that does not correspond to the entire amino acid sequence of XMRV p15E, wherein the amino acid sequence comprises an amino acid sequence selected from the group consisting of: SEQ ID NO: 83, SEQ ID NO: 84, and SEQ ID NO: 85.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.